Wang wanxia: Clinical Trials

2 trials sponsored by Wang wanxia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1

Follow Wang wanxia: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Ropivacaine Combined With Different Concentrations of Methylene Blue Fascia Iliaca Block in Postoperative Analgesia, Cognition, and Hip Function Recovery in Patients Undergoing Hip Arthroplasty
Ropivacaine combined with methylene blue for iliac fascia block - Femoral Neck Disease
Not applicableUnknownWang wanxia752024-03-152024-07-25
A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty
Ropivacaine combined with methylene blue for iliac fascia block - Femoral Neck Disease
Not applicableCompletedWang wanxia902023-06-202025-02-04

Interventions

Methylene Blue (2)

Countries

China (2)

Results publications

PMID 40087701